Medtronic (NYSE:MDT) is set to release its earnings data before the market opens on Thursday, May 23rd. Analysts expect Medtronic to post earnings of $1.47 per share for the quarter. Medtronic has set its FY19 guidance at $5.14-5.16 EPS.
Medtronic (NYSE:MDT) last announced its quarterly earnings results on Tuesday, February 19th. The medical technology company reported $1.29 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.05. The business had revenue of $7.55 billion during the quarter, compared to analysts’ expectations of $7.53 billion. Medtronic had a return on equity of 13.85% and a net margin of 16.10%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.17 EPS. On average, analysts expect Medtronic to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of NYSE MDT opened at $88.27 on Thursday. The company has a market capitalization of $117.32 billion, a P/E ratio of 18.51, a PEG ratio of 2.17 and a beta of 0.78. Medtronic has a 52 week low of $81.66 and a 52 week high of $100.15. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.36 and a quick ratio of 1.92.
Several equities research analysts recently commented on MDT shares. Barclays reissued a “buy” rating and issued a $104.00 price target on shares of Medtronic in a research note on Wednesday, February 20th. Oppenheimer set a $104.00 price target on Medtronic and gave the company a “buy” rating in a research note on Wednesday, February 20th. Northland Securities reissued a “hold” rating and issued a $84.00 price target on shares of Medtronic in a research note on Monday, March 18th. Wells Fargo & Co lowered their price target on Medtronic from $101.00 to $100.00 and set a “market perform” rating for the company in a research note on Thursday, April 4th. Finally, Citigroup boosted their price target on Medtronic from $95.00 to $101.00 and gave the company a “neutral” rating in a research note on Monday, February 25th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $103.39.
TRADEMARK VIOLATION WARNING: “Medtronic (MDT) to Release Earnings on Thursday” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2019/05/16/medtronic-mdt-to-release-earnings-on-thursday.html.
Medtronic Company Profile
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
Recommended Story: Put Option
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.